Matt, Author at European Medical Journal - Page 79 of 212

Anticipate Your Next Move in Chronic Myeloid Leukaemia Patient Management

Treatment decisions in chronic myeloid leukaemia (CML) are complex and require the evaluation of many factors at each stage of therapy…

Integrating Selective Targeted Monoclonal Antibody Therapies for Improved Outcomes in Uncontrolled Asthma

Atypical production of several Th2 cytokines, including IL-4, IL-5, and IL-13, play a central pathogenic role in multiple atopic conditions.

Editor's Pick: Identifying Shared Features and Addressing Common Challenges in Clinical Trials for Chronic Inflammatory Diseases: An Overview

Chronic inflammatory diseases (CID) encompass a wide range of pathologies affecting different organs or bodily functions…

Clustering by Health Professionals in Individually Randomised Controlled Trials

Researchers that individually randomised controlled trials (iRCT) assume that the observed outcomes of participants…

Immunotherapy and Oral Immunotherapy with Omalizumab for Food Allergies

Food allergy is potentially life-threatening and has a major impact on quality of life. Avoidance is currently the only approved therapy, and, although…

Adverse Pregnancy Outcomes in Asthmatic Women According to Steps of Treatment: A Population-Based Study

Bronchial asthma is the most common chronic disease in pregnancy associated with adverse pregnancy, obstetric, and perinatal outcomes.

The Role of the Gut Microbiome and its Derived Mediators in Nonalcoholic Fatty Liver Disease

Nonalcoholic fatty liver disease (NAFLD) has become an emerging disease throughout the world. Metabolic comorbidities such as obesity…

A Review of Liver Fibrosis and Emerging Therapies

With the increasing burden of liver cirrhosis, the most advanced stage of hepatic fibrosis, there is a need to better understand the pathological…

National Analyses on Survival in Maltese Adult Patients on Renal Replacement Therapy Started During 2009–2012

Chronic kidney disease patients on maintenance dialysis (CKD 5D) experience major morbidity and mortality. No data on survival in Maltese dialysis…

Boosting Cancer Immunotherapies with Optical Biosensor Nanotechnologies

Cancer immunotherapy has been profiled as one of the major breakthroughs of the decade and will probably remain a paramount biomedical landmark in…